OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Higher plasma β‐synuclein indicates early synaptic degeneration in Alzheimer's disease
Patrick Oeckl, Shorena Janelidze, Steffen Halbgebauer, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 5095-5102
Open Access | Times Cited: 12
Patrick Oeckl, Shorena Janelidze, Steffen Halbgebauer, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 5095-5102
Open Access | Times Cited: 12
Showing 12 citing articles:
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Burak Arslan, Henrik Zetterberg, Nicholas J. Ashton
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 6, pp. 1063-1069
Open Access | Times Cited: 23
Burak Arslan, Henrik Zetterberg, Nicholas J. Ashton
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 6, pp. 1063-1069
Open Access | Times Cited: 23
Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases
Johanna Nilsson, Alexa Pichet Binette, Sebastian Palmqvist, et al.
Brain (2024) Vol. 147, Iss. 7, pp. 2414-2427
Open Access | Times Cited: 21
Johanna Nilsson, Alexa Pichet Binette, Sebastian Palmqvist, et al.
Brain (2024) Vol. 147, Iss. 7, pp. 2414-2427
Open Access | Times Cited: 21
Challenges in the practical implementation of blood biomarkers for Alzheimer’s disease
Michael Schöll, Inge M.W. Verberk, Marta del Campo, et al.
The Lancet Healthy Longevity (2024) Vol. 5, Iss. 10, pp. 100630-100630
Open Access | Times Cited: 12
Michael Schöll, Inge M.W. Verberk, Marta del Campo, et al.
The Lancet Healthy Longevity (2024) Vol. 5, Iss. 10, pp. 100630-100630
Open Access | Times Cited: 12
Synapse vulnerability and resilience underlying Alzheimer’s disease
Raquel N. Taddei, Karen Duff
EBioMedicine (2025) Vol. 112, pp. 105557-105557
Open Access | Times Cited: 1
Raquel N. Taddei, Karen Duff
EBioMedicine (2025) Vol. 112, pp. 105557-105557
Open Access | Times Cited: 1
Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers
Dietmar Rudolf Thal, Koen Poesen, Rik Vandenberghe, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Dietmar Rudolf Thal, Koen Poesen, Rik Vandenberghe, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Monitoring synaptic pathology in Alzheimer’s disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectives
Simone Lista, Alejandro Santos‐Lozano, Enzo Emanuele, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 3, pp. 847-857
Closed Access | Times Cited: 5
Simone Lista, Alejandro Santos‐Lozano, Enzo Emanuele, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 3, pp. 847-857
Closed Access | Times Cited: 5
Impaired unfolded protein response, BDNF and synuclein markers in postmortem dorsolateral prefrontal cortex and caudate nucleus of patients with depression and Parkinson's disease
Unai Sarriés-Serrano, Lluís Miquel-Rio, Noemí Santana, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025) Vol. 138, pp. 111299-111299
Open Access
Unai Sarriés-Serrano, Lluís Miquel-Rio, Noemí Santana, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025) Vol. 138, pp. 111299-111299
Open Access
Fortschritte und Herausforderungen der Alzheimer-Diagnostik
Peter Findeisen
Trillium Diagnostik (2025) Vol. 23, Iss. 1, pp. 44-46
Closed Access
Peter Findeisen
Trillium Diagnostik (2025) Vol. 23, Iss. 1, pp. 44-46
Closed Access
Early increase of the synaptic blood marker β‐synuclein in asymptomatic autosomal dominant Alzheimer's disease
Patrick Oeckl, Benjamin Mayer, Randall J. Bateman, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 4
Open Access
Patrick Oeckl, Benjamin Mayer, Randall J. Bateman, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 4
Open Access
Sequential Proteomic Analysis Reveals the Key APOE4 ‐Induced Pathological and Molecular Features at the Presymptomatic Stage in Alzheimer's Disease Mice
Pengju Wei, Kaihua Lin, Xuhui Chen, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 3
Open Access
Pengju Wei, Kaihua Lin, Xuhui Chen, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 3
Open Access
Biomarkers of Synaptic Degeneration in Alzheimer’s Disease
Qian Cheng, Yiou Fan, Pengfei Zhang, et al.
Ageing Research Reviews (2024), pp. 102642-102642
Closed Access | Times Cited: 1
Qian Cheng, Yiou Fan, Pengfei Zhang, et al.
Ageing Research Reviews (2024), pp. 102642-102642
Closed Access | Times Cited: 1
Identification of lncRNA in circulating exosomes as potential biomarkers for MCI among the elderly
Jian Gao, Peiliang Chen, Zhihao Li, et al.
Journal of Affective Disorders (2024) Vol. 370, pp. 401-411
Closed Access
Jian Gao, Peiliang Chen, Zhihao Li, et al.
Journal of Affective Disorders (2024) Vol. 370, pp. 401-411
Closed Access
Prognostic serum biomarkers of synaptic, neuronal and glial injury in patients with acute ischemic stroke of the anterior circulation
Lorenzo Barba, Christoph Vollmuth, Steffen Halbgebauer, et al.
European Journal of Neurology (2024) Vol. 32, Iss. 1
Open Access
Lorenzo Barba, Christoph Vollmuth, Steffen Halbgebauer, et al.
European Journal of Neurology (2024) Vol. 32, Iss. 1
Open Access
